So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Kaya, Berna; Melhem, Hassan; Niess, Jan Hendrik researched the compound: 4-Hydroxyquinoline-2-carboxylic Acid( cas:492-27-3 ).COA of Formula: C10H7NO3.They published the article 《GPR35 in Intestinal Diseases: From Risk Gene to Function.》 about this compound( cas:492-27-3 ) in Frontiers in immunology. Keywords: GPR35; inflammatory bowel diseases; ligand-receptor interactions; metabolites; microbiota; risk variants. We’ll tell you more about this compound (cas:492-27-3).
Diet and gut microbial metabolites mediate host immune responses and are central to the maintenance of intestinal health. The metabolite-sensing G-protein coupled receptors (GPCRs) bind metabolites and trigger signals that are important for the host cell function, survival, proliferation and expansion. On the contrary, inadequate signaling of these metabolite-sensing GPCRs most likely participate to the development of diseases including inflammatory bowel diseases (IBD). In the intestine, metabolite-sensing GPCRs are highly expressed by epithelial cells and by specific subsets of immune cells. Such receptors provide an important link between immune system, gut microbiota and metabolic system. Member of these receptors, GPR35, a class A rhodopsin-like GPCR, has been shown to be activated by the metabolites tryptophan-derived kynurenic acid (KYNA), the chemokine CXCL17 and phospholipid derivate lysophosphatidic acid (LPA) species. There have been studies on GPR35 in the context of intestinal diseases since its identification as a risk gene for IBD. In this review, we discuss the pharmacology of GPR35 including its proposed endogenous and synthetic ligands as well as its antagonists. We elaborate on the risk variants of GPR35 implicated in gut-related diseases and the mechanisms by which GPR35 contribute to intestinal homeostasis.
Although many compounds look similar to this compound(492-27-3)COA of Formula: C10H7NO3, numerous studies have shown that this compound(SMILES:O=C(C1=NC2=CC=CC=C2C(O)=C1)O), has unique advantages. If you want to know more about similar compounds, you can read my other articles.
Reference:
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”